Login  
Volume 67
September 2006
Number 9

Original Articles   [top]

1323  Lipid Monitoring in Patients With Schizophrenia Prescribed Second-Generation Antipsychotics

[Full Text]

1327  Efficacy of Typical and Atypical Antipsychotics for Primary and Comorbid Anxiety Symptoms or Disorders: A Review

[Full Text]

1341  Substance Use Disorder and Other Predictors of Antidepressant-Induced Mania: A Retrospective Chart Review.

[Full Text]

1346  Lifetime Trauma Exposure in Veterans With Military-Related Posttraumatic Stress Disorder: Association With Current Symptomatology. [CME]

[Full Text]

1354  Selegiline Transdermal System for the Treatment of Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Trial

[Full Text]

1362  Implementation of the Texas Medication Algorithm Project Patient and Family Education Program

[Full Text]

1373  Association Study of the 5-HTTLPR Polymorphism and Depression in 75-Year-Old Nondemented Subjects From the Vienna Transdanube Aging (VITA) Study

[Full Text]

1379  Duloxetine in the Treatment of Major Depressive Disorder: Comparisons of Safety and Efficacy in U.S. Hispanic and Majority Caucasian Patients

[Full Text]

1391  Prevalence of Bone Mineral Density Loss in Korean Patients With Schizophrenia: A Cross-Sectional Study

[Full Text]

1397  The Relationship Between Quality of Life and Clinical Efficacy From a Randomized Trial Comparing Olanzapine and Ziprasidone

[Full Text]

1404  Clozapine Utilization and Outcomes by Race in a Public Mental Health System: 1994-2000

[Full Text]

1412  Realistic Expectations and a Disease Management Model for Depressed Patients With Persistent Symptoms. [CME]

[Full Text]

1422  Metabolic Syndrome and Depression: A Cross-Sectional Analysis

[Full Text]

1428  What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder?

[Full Text]

1435  Characteristics of E-Therapy Web Sites

[Full Text]

Commentary   [top]

1458  Commentary: Use of Treatment Algorithms for Depression. [CME]

[Full Text]

ASCP Corner   [top]

1466  ASCP Corner: Buprenorphine: Reflections of an Addictions Psychiatrist

[Full Text]

A Psychiatrist's Diary   [top]

1468  A Psychiatrist's Diary: Days Like This

[Full Text]

Letters to the Editor   [top]

1470  A Crossover Study of Prolactin Changes Associated With Risperidone and Olanzapine

[Full Text]

1470  Recurrent Priapism Associated With Use of Aripiprazole

[Full Text]

1471  Intimate Partner Violence Victimization Among Adults With Severe Mental Illness: Results of a Cross-Sectional Study

[Full Text]

1473  Internet Assessment of Obsessive-Compulsive Disorder

[Full Text]

1473  Hypertriglyceridemia Associated With Direct Effects of Olanzapine Rather Than With Weight Gain: A Case Report

[Full Text]

Book Reviews   [top]

1475  Medical and Psychiatric Comorbidity Over the Course of Life

[Full Text]

1475  Substance Abuse: A Comprehensive Textbook, 4th ed

[Full Text]

1475  Acute and Transient Psychosis

[Full Text]

Focus on Childhood and Adolescent Mental Health   [top]

1441  Focus on Childhood and Adolescent Mental Health: Phenomenological Considerations of Childhood and Adolescent Psychopathology

[Full Text]

1442  Clinical Features of Depressed Children and Adolescents With Various Forms of Suicidality

[Full Text]

1451  Possible Link Between Childhood Separation Anxiety and Adulthood Personality Disorder in Patients With Anxiety Disorders in Japan

[Full Text]

Psychiatrist.com Exclusives:Free Online Activities   [top]

8  Comorbid Schizophrenia and Substance Abuse. [Free Access]

[Full Text]

9  Neuroprotection in Schizophrenia. [Free Access]

[Full Text]

10  Update on Bipolar Disorder and Substance Abuse: Recent Findings and Treatment Strategies [Free Access]

[Full Text]

11  The Neurobiology of Cognition in Schizophrenia [Free Access]

[Full Text]



information for authors

see www.psychiatrist.com/pages/author.aspx